Molecular imaging in drug development

@article{Willmann2008MolecularII,
  title={Molecular imaging in drug development},
  author={J. Willmann and N. Bruggen and L. Dinkelborg and S. Gambhir},
  journal={Nature Reviews Drug Discovery},
  year={2008},
  volume={7},
  pages={591-607}
}
Molecular imaging can allow the non-invasive assessment of biological and biochemical processes in living subjects. Such technologies therefore have the potential to enhance our understanding of disease and drug activity during preclinical and clinical drug development, which could aid decisions to select candidates that seem most likely to be successful or to halt the development of drugs that seem likely to ultimately fail. Here, with an emphasis on oncology, we review the applications of… Expand
View on Nature
ncbi.nlm.nih.gov
717 Citations
Highly Influential Citations
12
Background Citations
138
Methods Citations
25

717 Citations

Citation Type

Citation Type

The role of molecular imaging in modern drug development.
TLDR
The modern concept and future trends concerning molecular imaging will assumedly be hybrid or multimodality imaging, including combinations between high sensitivity and functional (molecular) modalities with high spatial resolution and morphological techniques. Expand
Molecular imaging with SPECT as a tool for drug development.
TLDR
The potential applications of SPECT imaging in the drug development process is reviewed with an emphasis on its applications in exploratory IND studies. Expand
New imaging paradigms in drug development: the PET imaging approach.
TLDR
The presented review highlights few state-of-the-art examples that serve to illustrate specific points and discuss future directions of the use of positron emission tomography (PET) imaging in various phases of clinical drug development. Expand
Applications of Small-Animal Molecular Imaging in Drug Development
TLDR
This chapter will summarize and evaluate the applications of various advanced small animal imaging techniques in drug development process and create more sensitive, specific and higher resolution measurements within living organism, especially small animals. Expand
Noninvasive structural, functional, and molecular imaging in drug development.
  • M. Rudin
  • Biology, Medicine
  • Current opinion in chemical biology
  • 2009
TLDR
The role and potential of imaging in modern drug discovery and development is illustrated with selected examples and it is beyond doubt that their importance for biomedical research will increase. Expand
Molecular imaging with bioconjugates in mouse models of cancer.
  • S. Mather
  • Biology, Medicine
  • Bioconjugate chemistry
  • 2009
TLDR
This review gives an overview of the technologies available for and the potential benefits from molecular imaging at the preclinical stage and focuses on the use of imaging probes based on bioconjugates. Expand
Imaging as a Localized Biomarker: Opportunities and Challenges
In recent years, the concept of imaging biomarkers is increasingly being utilized in drug development and for producing images of physiological and physicochemical processes in a living subject.… Expand
Has Molecular and Cellular Imaging Enhanced Drug Discovery and Drug Development?
TLDR
Several important applications of molecular and cellular imaging in drug discovery and development are discussed, which include: measurement of pharmacodynamic endpoints by imaging metabolism and proliferation, imaging angiogenic parameters, and imaging a particular pathway or downstream target. Expand
Molecular imaging of membrane drug efflux transporters activity in cancer
Abstract Molecular imaging involves minimally-invasive quantitative measurement of biological processes in vivo, complementing biosample-based analyses. Molecular imaging can provide unique insight… Expand
Chapter 35 – Use of Imaging for Preclinical Evaluation
TLDR
This chapter illustrates the basic principles of multiple imaging platforms, including single-photon emission computed tomography (SPECT), positron emissiontomography (PET), magnetic resonance imaging (MRI), quantitative whole-body autoradiography (QWBA), computed tomographies (CT), ultrasound (US), and optical (bioluminescence/fluorescence) imaging technology. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 185 REFERENCES
Using imaging biomarkers to accelerate drug development and clinical trials.
TLDR
In this review, examples from oncology, neurology, psychiatry, infectious diseases and inflammatory diseases are used to illustrate the role imaging can play and some remarks concerning new developments that will be required to significantly advance the field of pharmaco-imaging are concluded. Expand
Molecular imaging in drug discovery and development
TLDR
This review summarizes some of the recent developments in conventional and molecular imaging, and highlights their impact on drug discovery. Expand
Molecular Imaging in Drug Discovery and Development: Potential and Limitations of Nonnuclear Methods
TLDR
The role of molecular imaging for drug discovery and development is reviewed focusing on nonnuclear imaging methods, i.e., magnetic resonance imaging (MRI) and optical imaging techniques based on fluorescence and bioluminescence readouts, including direct visualization of target expression using target-specific ligands or reporter genes, pathway imaging, and cell-trafficking studies. Expand
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
TLDR
The scientific basis of oncology imaging probes is outlined and examples of probes that could facilitate progress are presented, with a focus on recent Food and Drug Administration guidance to facilitate early clinical development of promising probes. Expand
How molecular imaging is speeding up antiangiogenic drug development
TLDR
The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelium growth factor receptor, integrin αvβ3, matrix metalloproteinase, endoglin, and E-selectin. Expand
Molecular imaging of antiangiogenic agents.
TLDR
The role of molecular imaging in general, and DCE-MRI in particular, in relation to treatment with antiangiogenic agents is discussed and some of the difficulties encountered are highlighted. Expand
Medical imaging in pharmaceutical clinical trials: what radiologists should know.
The role of medical imaging in pharmaceutical clinical trials includes identification of likely responders; detection and diagnosis of lesions and evaluation of their severity; and therapy monitoring… Expand
Molecular imaging applications for immunology.
TLDR
The current field of molecular imaging assays (especially those utilizing PET and BIm modalities) are reviewed and how they might impact animal models and human disease in the field of clinical immunology is examined. Expand
Clinical molecular imaging with positron emission tomography.
TLDR
The principles of PET and its currently accepted applications in oncology, such as cancer staging, treatment response assessment and as a prognostic marker are reviewed. Expand
Gene therapy imaging in patients for oncological applications
TLDR
The current status of gene therapy-based anticancer strategies are presented and how molecular imaging, and more specifically radionuclide-based approaches, can be used in gene therapy procedures for oncological applications in humans are shown. Expand
...
1
2
3
4
5
...